PDE10A as a novel diagnostic and therapeutic target in cancer: insights and challenges.

Notably, they revealed that in North American men, who had much higher baseline use of PDE5 inhibitors, this treatment was associated with an inverse trend of prostate cancer diagnosis, but did not reach statistical significance ( 120 ).

also in 111,027 other papers